Pulmonary medium vessel vasculitis in an 11 year old boy: Hughes Stovin syndrome as a variant of polyarteritis nodosa? by Willemien de Vries et al.
CASE REPORT Open Access
Pulmonary medium vessel vasculitis in an 11 year
old boy: Hughes Stovin syndrome as a variant of
polyarteritis nodosa?
Willemien de Vries1, Gerard H Koppelman2, Marc TR Roofthooft3,4, Hendrika Bootsma6, Martha K Leijsma6 and
Wineke Armbrust5*
Abstract
We present the case of an 11-year-old boy presenting with haemoptysis, dyspnoea and weight loss as a
manifestation of isolated pulmonary vasculitis, leading to pulmonary hypertension. He also appeared to have a
longstanding dural venous sinus thrombosis. This rare presentation, especially in childhood, might represent a case
of the seldomly reported Hughes-Stovin syndrome. The patient achieved remission after therapy with
cyclophosphamide pulses and high-dose steroids. Based on the presented case and review of the literature, we
propose that this syndrome might be a variant of polyarteritis nodosa. This report highlights diagnostic issues and
describes a successful treatment regimen.
Background
According to the EULAR/PRINTO/PReS consensus cri-
teria vasculitis of childhood is classified as small, med-
ium-sized or large vessel vasculitis, or ‘other’ [1]. In
childhood, pulmonary involvement is most frequently
observed in vasculitis which preferentially affects small
vessels, such as Wegener’s granulomatosis, microscopic
polyangiitis and Churg-Strauss syndrome. Pulmonary
involvement is seldomly observed in large and medium
vessel vasculitis, such as Takayasu arteritis, Kawasaki
disease and polyarteritis nodosa (PAN) [1-3]. An excep-
tion is Behçet’s disease (BD), in which the formation of
pulmonary artery aneurysms occurs in 1-8% of adult BD
patients. Similar rates have been found in pediatric case
series [2,4-6].
In this report we describe an eleven-year-old boy suf-
fering from pulmonary medium sized vessel vasculitis,
combined with dural venous sinus thrombosis. We high-
light the difficulty in establishing a definite diagnosis in
the context of current diagnostic criteria and discuss
Hughes-Stovin syndrome (HSS) as a potential diagnosis.
HSS is characterized by the combination of multiple
bilateral pulmonary artery aneurysms and venous
thrombosis, and has been suggested to be an incomplete
variant of BD [5,7]. We will review pediatric cases of
HSS from the literature and discuss the possibility that
it is rather a variant of PAN with specific pulmonary
involvement, based on its clinical manifestations in rela-
tion to current diagnostic guidelines and its therapeutic
response.
Case Presentation
An 11-year-old boy was admitted to our hospital with
cough, fatigue, and weight loss (~4 kg) of 4 months
duration, and hemoptysis starting the day before admis-
sion. The past medical history was unremarkable. His
mother was Spanish, his father Dutch. The family medi-
cal history was negative for autoinflammatory or auto-
immune diseases.
Clinical examination was unremarkable other than a
pale appearance. No oral or genital ulcers were present.
Laboratory examination revealed elevated inflammatory
parameters (ESR 59 mm/h (normal, 3-13 mm/h); CRP
69 mg/L (normal < 5 mg/L); leucocytes 12.2*109/L (nor-
mal, 4.0-10.0*109/L); microcytic anemia (Hemoglobin
6.2 mmol/L (normal, 6.6-9.3 mmol/L); MCV 65.9 fl
(normal, 80-94 fl)); and normal renal function (serum
creatinin 42 μmol/L (normal, 31-68 μmol/L), urinary
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protein excretion 0.1 g/24 h (normal, < 0.3 g/24 h)).
Tuberculin skin test, pathergy test, plasma lupus antic-
oagulant, anti-cardiolipins, direct Coombs test, angioten-
sin converting enzyme, ANA and ANCA were negative.
A chest X-ray showed a broad mediastinum, without
pulmonary abnormalities. A CT-scan showed an
enlarged subcarinal mediastinal mass branching towards
both pulmonary hili, without parenchymal disease. The
patient developed febrile episodes every afternoon (up
to 39°C), and complained of mild myalgia. Diagnostic
considerations included atypical pneumonia, tuberculo-
sis, lymphoma, sarcoidosis, autoimmune and autoinflam-
matory disorders.
A bronchoscopy with transbronchial biopsy and bron-
chial alveolar lavage was performed. The biopsy results
were not consistent with malignancy or sarcoidosis but
were not conclusive. Therefore, a cervical mediastino-
scopy was performed, and histological examination of
the enlarged lymph node revealed no signs of malig-
nancy, tuberculosis or sarcoidosis, but a reactive pattern
with numerous lymphocytes, lymphoblasts and plasma
cells. Culture of sputum, blood, stomach contents,
bronchoalveolar lavage fluid and serology could not
identify an infectious cause explaining the reactive
lymphadenopathy.
Evaluation by an ophthalmologist for autoimmune
related eye disease showed bilateral papilledema. There
were no further symptoms of a raised intracranial pres-
sure. Magnetic resonance imaging of the cerebrum
showed dural venous sinus thrombosis with extensive
collateral vessel formation (Figure 1A). Six weeks after
admission, the patient again developed hemoptysis. Phy-
sical examination now revealed a cardiac murmur, due
to tricuspid regurgitation, and a loud second heart
sound, suggesting pulmonary hypertension. This was
confirmed by cardiac catheterization. The mean pressure
in the left pulmonary artery was 30 mmHg, the pulmon-
ary wedge pressure was 13 mmHg, the cardiac index
was 2 l/min/m2, and the pulmonary resistance measured
8.4 resistant units per m2, thus indicating moderate pul-
monary hypertension. Angiography and CT-angiography
showed multiple aneurysms in the medium sized
arteries (pulmonary artery, Figure 1B). The abdominal,
cervical and coronary arteries were also investigated by
angiography and appeared unaffected. The performance
of an open lung biopsy was considered too risky because
of the patient’s clinical condition.
Under the working diagnosis of medium-sized vessel
vasculitis with moderate pulmonary hypertension as a
consequence, the patient was treated with intravenous
gamma globulin (2 g/kg) for two days, intravenous pre-
dnisolone (35 mg/day) and cyclophosphamide (750 mg/
m2, once per month, 12 pulses), sildenafil (40 mg/day)
and bosentan (125 mg/day). Anticoagulation therapy
was initiated in the acute phase but stopped after one
week. Ten days thereafter the patient developed recur-
rent hemoptysis.
Twenty-five days after initiation of the anti-inflamma-
tory treatment, the ESR returned to the normal range;
however, after five weeks the patient developed massive
bleeding in his respiratory tract. The aneurysmal right
bronchial artery was identified as the focus of the bleed-
ing by digital substraction angiography and embolized
with microspheres. The patient required mechanical
ventilation and was treated in the intensive care unit for
three weeks. After ten weeks he was sufficiently recov-
ered to be discharged. The exercise tolerance was
severely decreased but improved gradually as demon-
strated by the results of the 6 minutes walk test. Seven
weeks after embolization, the walked distance was 178
meters; eighteen months later this had improved to 442
meters. However, the walked distance is still below
reported results from healthy age-matched males [8].
After the final cyclophosphamide pulse azathioprine
was started (2 mg/kg/day, for 2 years). Steroids were
tapered gradually and discontinued 18 months after
initiation of therapy. No important side effects of the
medication occurred. Currently, after eighteen months
of treatment, the patient is still in remission. The
inflammatory parameters are not elevated and fever is
absent. Upon re-evaluation on CT scan, there were only
minor residual vessel wall derangements visible at the
site of the former aneurysms. The follow-up of the pul-
monary hypertension was done indirectly by cardiac
ultrasonography and showed no increase of pulmonary
hypertension. Sildenafil and bosentan are continued.
The papilledema had resolved, cerebral imaging was not
repeated.
Figure 1 Figure 1: Imaging studies demonstrating pulmonary
aneurysms and venous sinus thrombosis. A)Magnetic resonance
venography of the venous sinus, demonstrating extensive formation
of venous collaterals.B)Angiography of the right pulmonary artery.
The angiography demonstrates multiple aneurysms (arrow),
enlargement of central pulmonary arteriesand abruptly diminished
calibre of peripheral pulmonary vessels.
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Discussion
We present a case of recurrent hemoptysis and pulmon-
ary hypertension in an 11-year-old boy. The symptoms
of the patient appeared to be the result of an inflamma-
tory destructive process solely affecting the medium
sized pulmonary and bronchial vessels. However, the
involvement of both pulmonary and systemic vessels
makes classification of the disease difficult.
The vasculitis of medium-sized vessels described in
this report might be classified as PAN because the
patient met the full diagnostic criteria of childhood
PAN, that include: angiographic or histologic abnormal-
ities combined with myalgia, and symptoms suggesting
involvement of a major organ system [1].
PAN is a vasculitis typically involving medium sized
vessels and the disease is rare in childhood with an inci-
dence of < 1 in 1 million [9]. PAN most commonly
involves skin, joints, peripheral nerves, gastrointestinal
tract and kidney, and disease manifestations are diverse.
Pulmonary involvement is rare but was described to
occur in ~11% of juvenile systemic PAN cases [10]. In
the same study, 8 out of 56 (14%) juvenile PAN patients
had aneurysms in central nervous system arteries. Pul-
monary involvement in PAN includes arteritis of bron-
chial arteries, but diffuse alveolar damage and interstitial
fibrosis have also been detected in autopsy cases [11].
The risk of venous thrombosis in PAN is higher com-
pared to the general population [12,13], which may be
attributable to the systemic inflammation. In the pre-
sented case, all prothrombotic factors examined (lupus
anticoagulant, anti-cardiolipins) were negative. To our
knowledge, the incidence of venous sinus thrombosis in
PAN has not been studied.
HSS is characterized by multiple bilateral pulmonary
artery aneurysms and venous thrombosis [5,7,14].
Hughes and Stovin described this syndrome for the first
time in 1959. To our knowledge, only four pediatric
cases have been described, aged 12, 14 (twice) and 16
(Table 1) [14,15]. The pathogenesis of this disease
remains speculative, and previously it has been sug-
gested that HSS is an incomplete variant of BD based
on the occurrence of pulmonary vasculitis and venous
thrombosis in both disease entities [5,7]. Review of adult
and pediatric cases showed that no history of oral ulcers
has been described in the context of HSS. That is man-
datory for the diagnosis of BD as the diagnostic criteria
include oral ulcers combined with two of the following
symptoms: genital ulcers, ocular lesions, skin lesions,
positive pathergy test (Table 1) [4,6,16].
We argue, given the symptoms described in the cur-
rent and previous case reports, that it is more likely that
HSS is a variant of PAN rather than BD. This would
apply to children and adults, as the diagnostic criteria
do not differ in this respect. The presented case fulfills
the diagnostic criteria with angiographic abnormalities
of medium-sized vessels, and myalgia. In other pub-
lished HSS cases, the presence or absence of mylagia or
one of the other minor criteria for the diagnosis of
PAN, are not mentioned. The therapeutic approach to
HSS is similar to that of PAN, as both respond well to
cyclophosphamide courses [17]. Our case illustrates the
beneficial effect of a treatment regimen entailing a com-
bination of high-dose steroids and cyclophosphamide
pulses.
Conclusions
In summary, we present a case of isolated pulmonary
vasculitis with involvement of both the pulmonary and
bronchial vessels and concomitant dural venous sinus
thrombosis in an 11-year-old boy. The presentation of
pulmonary vasculitis with lymphadenopathy, fever,
weight loss, and hemoptysis as presented in this report
has a broad differential diagnosis, including infections,
malignancies and inflammatory disease. This may well
represent a case of HSS. Based on our findings and pre-
vious case reports we argue that HSS might be a disease
closely related to PAN. We cannot support this specula-
tion with histological findings, since it was impossible to
Table 1 Pediatric cases of Hughes Stovin Syndrome







m 14 PAA, CVST nr nr nr +
m 14 PAA, CVST,
DVT
nr nr + + prednisolone
Roberts
[15]
m 12 PAA, DVT nr nr nr + surgery
Emad [7] m 16 PAA, CVST,
DVT
- nr - + prednisolone, azathioprin
This report m 11 PAA, CVST - + - + cyclophosphamide
prednisolone
m: male; PAA: pulmonary artery aneurysms; CVST: cerebral venous sinus thrombosis; DVT: deep venous thrombosis;
nr: not reported; + symptom present; - symptom absent.
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obtain histology in the presented patient. Treatment
with high-dose steroids and cyclophosphamide induced
remission and thus might be an effective therapeutic
regimen in (pediatric) cases of HSS.
Consent
Written informed consent was obtained from the
patient’s parents for publication of this case report and
any accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
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